tirzepatide pregnancy discontinue before conception label Discontinuing GLP-1s Before or Early in Pregnancy Tied to Weight Gain, Pregnancy Complications These highlights do not include

The appetite suppression may reduce absorption of oral contraceptives taken around the time of tirzepatide injection, though this interaction has not been formally studied

Role of GLP-1 and GIP in Cardiovascular Outcomes Both GIP and GLP-1 have exhibited beneficial effects on various cardiovascular complications, thereby shedding light on their therapeutic potential over and above their potential to improve diabetic complications

For example: If the mother has strong side effects or the baby shows changes in feeding or growth, tirzepatide may be stopped The doctor may try a lower dose or a different schedule to reduce risk The mother may choose to stop breastfeeding if tirzepatide is medically necessary and no better options are available Every decision should be made by looking at the benefits and risks for both mother and child

Tirzepatide Niacinamide Injection

Some weight regain is normal at this stage, typically 5-10 pounds

Measure carefully with a 3 mL syringe, not an insulin syringe which maxes out at 1 mL and would require multiple draws